Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/2007
07/03/2007US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders
07/03/2007US7238690 Substituted heterocycle fused gamma-carbolines
07/03/2007US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
07/03/2007US7238687 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
07/03/2007US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation
07/03/2007US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
07/03/2007US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
07/03/2007US7238666 Method of inhibiting fibrosis with a somatostatin agonist
07/03/2007US7238658 Treating agonist disorders including obesity, and hyperglycemic, whole body growth, immunological, kidney, neurological and neuromuscular disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern
07/03/2007US7238657 Cartilage/Bone inducing materials for preparation
07/03/2007US7238487 Therapeutic agent for fibromyalgia
07/03/2007US7238469 Administering to a donor a pharmaceutical composition containing carbon monoxide, obtaining an organ, tissue or cell and transplanting to a recipient
07/03/2007US7238377 Use of an oil of the gourd family for inhibiting 5 alpha-reductase activity
07/03/2007US7238367 Liposome loading with metal ions
07/03/2007CA2522232C Cross-linked polysaccharide composition
07/03/2007CA2397258C Preparation of sulfonamides
07/03/2007CA2384859C High lipid diet
07/03/2007CA2382548C Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
07/03/2007CA2319096C Method for treating acute intermittent porphyria (aip) and other porphyric diseases
07/03/2007CA2260774C Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
07/03/2007CA2252465C Urea derivatives as inhibitors of impdh enzyme
06/2007
06/28/2007WO2007073006A1 Inducer for increasing of content of cytoprotective amino acid and method for increasing the content
06/28/2007WO2007072971A1 Agent for improving angiopathy containing sulfated polysaccharide derived from green alga and method for producing the same
06/28/2007WO2007072923A1 Preparation for external use having improved temporal stability of steroid
06/28/2007WO2007072869A1 Amorphous form of 1,2-dihydropyridine compound
06/28/2007WO2007072868A1 Crystal of 1,2-dihydropyridine compound (type iv)
06/28/2007WO2007072866A1 Anti-ilt7 antibody
06/28/2007WO2007072851A1 Process for production of water-soluble azole prodrug
06/28/2007WO2007072782A1 Carboxylic acid derivative or salt thereof
06/28/2007WO2007071967A2 Substituted phenol derivatives as analgesics
06/28/2007WO2007071605A1 The use of st1898 for the treatment of restenosis
06/28/2007WO2007071158A1 Antiperspirant compositions
06/28/2007US20070149619 Anti-aging agent
06/28/2007US20070149587 Valsartan Salts
06/28/2007US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity
06/28/2007US20070149571 Combination therapy for treating or managing acute myelocytic leukemia
06/28/2007US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay
06/28/2007US20070149563 N-(1-Azabicyclo[2.2.2]oct-3-yl)(2-(3-pyridyl)thiazole-4-carboxamide); nicotinic acetylcholine receptor ligands; psychotic and intellectual impairment disorders; antidepressant, anxiolytic agent; Alzheimer's disease, cognitive or attention disorders
06/28/2007US20070149558 Benzo-fused 5-membered heterocyclic compounds, their production and use
06/28/2007US20070149555 Prophylatic and/or therapeutic agents for chronic musculoskeletal pain
06/28/2007US20070149539 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia
06/28/2007US20070149536 2-[4-Bromomethyl)phenyl-3-phenylquinoxaline 1-2; selectively inhibits one or two of the serine/threonine protein kinase isoforms; antiproliferative
06/28/2007US20070149476 Combination Comprising Combretastatin and Anticancer Agents
06/28/2007US20070148734 Hyaluronic acid mediated adenoviral transduction
06/28/2007US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay
06/28/2007US20070148261 Cancer treatment method
06/28/2007US20070148256 Pharmacologic-functioning water and usage of the same
06/28/2007US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
06/28/2007US20070148209 Allergic constitution ameliorator
06/28/2007US20070148189 Stable Liquid Formulations of Botulinum Toxin
06/28/2007US20070148158 Rationally designed heparinases derived from heparinase II
06/28/2007DE20122735U1 Verwendung einer Zubereitung für Restenoseprophylaxe Use of a composition for prophylaxis of restenosis
06/28/2007DE102005062145A1 Ingwerextrakt zur Inhibierung humaner Arzneistofftransporter Ginger extract to inhibit human drug transporters
06/28/2007CA2634116A1 Anti-ilt7 antibody
06/28/2007CA2634056A1 Amorphous form of 1,2-dihydropyridine compound
06/28/2007CA2632842A1 Process for preparation of water-soluble azole prodrugs
06/28/2007CA2632561A1 Substituted propofol derivatives as analgesics
06/27/2007EP1801231A1 Method of screening baff suppressor or inhibitor
06/27/2007EP1801216A2 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
06/27/2007EP1801123A2 Crystals of whole antibodies and fragments thereof and methods for making and using them
06/27/2007EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same
06/27/2007EP1801112A1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
06/27/2007EP1801108A1 Morpholine compound
06/27/2007EP1800697A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas
06/27/2007EP1800670A1 Micellar drug delivery systems for hydrophobic drugs
06/27/2007EP1800666A1 Nanoparticulate compositions of angiogenesis inhibitors
06/27/2007EP1799683A1 Hexahydro-pyrazino[1,2-a]pyrimidine-4, 7-dione derivatives substituted with amino acids
06/27/2007EP1799641A1 Process for the preparation of amorphous fluvastatin sodium
06/27/2007EP1799250A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions
06/27/2007EP1799230A2 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
06/27/2007EP1799213A2 Novel curcumin analogues and uses thereof
06/27/2007EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis
06/27/2007EP1392259B1 Delivery of erectile dysfunction drugs through an inhalation route
06/27/2007EP1368312B1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor
06/27/2007EP1311264B1 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom
06/27/2007EP1219630B1 Immunopotentiating compositions
06/27/2007EP1212063B1 Topical azathioprine for the treatment of oral autoimmune diseases
06/27/2007EP1140873B1 Il-5 inhibiting 6-azauracil derivatives
06/27/2007EP1115383B1 Treatment of acute disorders by sublingual administration of a pharmaceutical composition
06/27/2007EP1107986B1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same
06/27/2007EP1107743B1 Stable spray-dried protein formulations
06/27/2007EP1047676B1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
06/27/2007CN1989245A Novel galectin 8 modification protein and use thereof
06/27/2007CN1989123A Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity
06/27/2007CN1986567A Japanese blood fluke specific female fluke sex gene and its coded protein and application
06/27/2007CN1986566A Japanese blood fluke specific female fluke gene and its coded protein and application
06/27/2007CN1986565A Japanese blood fluke specific sex relevant gene and its coded protein and application
06/27/2007CN1986564A Japanese blood fluke specific female fluke gene and its coded protein and application
06/27/2007CN1986563A Japanese blood fluke epidermal protein gene and protein and their application
06/27/2007CN1985966A Chinese medicine composition for treating headache, diziness and other diseases caused by liver and kidney deficiency and liver wind
06/27/2007CN1985963A Medicine for treating organ cyst and its preparing method
06/27/2007CN1985960A Slow released capsule of clarithromycin and bletilla tuber glue for animal and birs
06/27/2007CN1985920A Preparation for clearing away heat and toxic matter and its new preparing process
06/27/2007CN1985888A Medicine for raising hypoxia tolerance and remitting physical fatigue and its use
06/27/2007CN1985884A Sunstroke treating plaster and its preparing method
06/27/2007CN1985855A Ginkgo health vinegar recipe and preparing method
06/27/2007CN1985844A Preparing process of magnetic adsorbent and its application in treating hyperbilirubinemia
06/27/2007CN1985829A Stammering treating medicine and its preparing method
06/27/2007CN1985664A Double egg white food for teenage and its making process
06/27/2007CN1323080C Pyrimido compounds having antiproliferative activity